Back to
Quadrature Capital Ltd
IOVA
6 quarters
Position history for
Quadrature Capital Ltd's holdings in Iovance Biotherapeutics, Inc.
Yes. Quadrature Capital holds 278,937 shares of IOVA (Iovance Biotherapeutics), worth $1.2M, as of its Q2 2026 13F filing. It increased the position by 120,008 shares (+75.5%) from Q1 2026. Quadrature Capital has held IOVA since Q4 2025, across 3 quarterly 13F filings.
Current Value
$1.2M
Current Shares
278,937
Total Value Change
+$1.1M
Total Shares Change
+246,205
Quarter-by-Quarter History